Position in DNA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$188,944
+$146,738 QoQ
Shares Held
19,066
+275.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 183 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Derivatives in DNA
reported options exposure · as of Jun 30, 2026CallValue
$42,613
CallShares
4,300
PutValue
$101,082
PutShares
10,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. DNA ranks #93 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in DNA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $188,944 | 19,066 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $101,082 | 10,200 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $42,613 | 4,300 | Call | Sole | 2026-08-03 | |
| 2025-12-31 | $42,206 | 5,079 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $34,071 | 4,100 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $277,554 | 33,400 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $122,472 | 8,400 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $23,328 | 1,600 | Call | Sole | 2025-11-14 | |
| 2024-12-31 | $71,686 | 7,300 | Call | Sole | 2025-02-13 | |
| 2024-12-31 | $138,462 | 14,100 | Put | Sole | 2025-02-13 | |
| 2024-12-31 | $2,613,386 | 266,129 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $92,095 | 11,300 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $141,321 | 17,340 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $141,810 | 17,400 | Call | Sole | 2024-11-14 | |
| 2024-06-30 DNABW | — | 1,646,466 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 DNABW | — | 1,646,466 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 DNABW | — | 1,646,466 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 DNABW | — | 1,526,482 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 DNABW | — | 1,542,737 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 DNABW | — | 530,602 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 DNABW | — | 284,160 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $80,600 | 20,000 | Call | Sole | 2022-05-27 | |
| 2021-12-31 DNABW | — | 241,033 | Shares | Sole | 2022-05-27 | |
| 2021-09-30 DNABW | — | 31,946 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||